R&D Commitment Hero Image

R&D Commitment

The lifeblood of health is research and discovery (R&D). That’s why America’s Biopharmaceutical Companies recently announced a bold new commitment to the R&D of new treatments and cures for patients

LATEST ARTICLES

Rare Disease by the Numbers

Today is Rare Disease Day, which serves as a time to recognize the more than 30 million Americans li…

READ MORE

Our Commitment

We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough an…

READ MORE

Advancing Innovation in San Diego

As a senior research advisor at the Eli Lilly and Co. Biotechnology Center in San Diego, Stephen Dem…

READ MORE

America's Biopharmaceutical Industry Is Central to Diverse R&D Ecosystem

America's biopharmaceutical companies are at the heart of a robust research and development (R&D…

READ MORE

Lifecycle from Brand to Generic

Where do generic drugs come from? Medicines have a long lifecycle from research to brand name drug t…

READ MORE

How Can Biomarkers and Surrogate Endpoints Enhance R&D of Medicines?

In the age of personalized medicine, biomarkers are emerging as important tools in drug development.

READ MORE

Do Not Go Gentle

Finding lifesaving medicines is a life's work – the work of thousands of researchers who never say n…

READ MORE

Treating Autoimmune Diseases: More than 300 Medicines in the Pipeline

More than 23.5 million Americans are affected by an autoimmune disease. Biopharmaceutical researcher…

READ MORE

RELATED ARTICLES

Getting Ahead of Migraines

Understanding migraines fully can give patients back time taken by the disease.

READ MORE

Clinical Trials: The Key to Innovative New Medicines

As we celebrate Clinical Trials Awareness Week, we're taking a moment to recognize the important rol…

READ MORE

World IP Day: How Intellectual Property Protections Spur Innovation

Every April 26, we celebrate World Intellectual Property Day as a way to remember the critical role…

READ MORE

Recognizing Diversity in Clinical Trials

Every time you take a medicine – even if it's just for a headache – you are benefitting from the res…

READ MORE

Researcher Profile: Paul Nioi

Paul is a scientist in the Research and Development Group at Amgen where he is focused largely on th…

READ MORE

Researcher Profile: Matthew Kennedy

Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to o…

READ MORE

Researcher Profile: Pablo Sardi

Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He starte…

READ MORE

Florida Clinical Trials

Recently, America's biopharmaceutical companies joined the American Cancer Society for the Cancer Ac…

READ MORE

A Pipeline of Promise: Immuno-oncology

We are in a new era of medicine, powered in part by the advancements and innovations being made in t…

READ MORE

What's Next? Discovery, Treatments and Cures in the Biopharmaceutical Pipeline

For many patients, the biopharmaceutical pipeline is their best hope for a cure or a longer, healthi…

READ MORE

Researcher Profile: Christina Trout

Christina works in the Epigenetic Department at Celgene as a research scientist, exploring a number…

READ MORE

The Power of Partnership in Genomic Medicine

Leading minds were recently brought together from the biopharmaceutical industry to research organiz…

READ MORE

A New World of Medicine

Join us on a journey deep into the new frontier of medicine. Explore how immunotherapy can take the…

READ MORE

The Next Generation of Research

Industry leaders came together for "Sequencing the Genome: Examining Modern Medicine," a conversatio…

READ MORE

No Stone Unturned in Mental Health Research

Treating patients with mental health disorders is about getting to know the person behind the diseas…

READ MORE

The New Era of Medicine with Stephen Ubl

We are in a new era of medicine where innovations are transforming our ability to attack the cause o…

READ MORE

Brain Awareness Week

For all we have accomplished in neuroscience, our understanding of human brain function and the dise…

READ MORE

How Medical Technology Is Saving Lives

Meet inspiring individuals who were diagnosed with a serious medical condition and learn how advance…

READ MORE

Research Doesn’t End On A Medicine’s Approval

Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief…

READ MORE

Cumulative Steps, Big Gains for Patients

Advances in treating debilitating diseases are often not the result of one single breakthrough, but…

READ MORE

Brain Cancer: Research Brings Hope to a Difficult Disease

Between 1998 and 2014, there were 75 unsuccessful drugs and 3 approved drugs for brain cancer.

READ MORE

A Decade of Innovation in Treatment for Multiple Sclerosis (MS) Patients

Ten years ago, treatments were limited to a handful of medicines. Today, MS patients have more treat…

READ MORE

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

Investment is a key driver of innovation across all industries. However, investment is especially im…

READ MORE

Multiple Sclerosis: Then and Now

While there is no cure for multiple sclerosis (MS), a decade of innovation has changed the way we tr…

READ MORE

A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six

Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affecte…

READ MORE

The Promise of Personalized Medicine

Discover how America's Biopharmaceutical Companies developed groundbreaking weapons to destroy the b…

READ MORE